// App-Quantinova.ai

[FRI0403] : MESANGIAL PROLIFERATIVE LUPUS NEPHRITIS (ISN/RPS CLASS II): CLINICAL AND PROGNOSIS IN A COHORT OF 45 PATIENTS

Researchers

Presenter

  • G. Albert

Principal Investigators

  • J. Narvaez

  • M. Ricse

  • P. Estrada

  • A. Zacarias

  • M. Pestana

  • C. Mora

  • A. Rozadilla

  • X. Fulladosa

  • J. M. Nolla

  • M. Rubio Rivas

Medical Centers

  • Hospital Universitari Bellvitge, IDIBELL, Hospitalet Llobregat, Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Renal insufficiency

  • Nephrotic syndrome

  • Lupus nephritis

  • Renal disease

  • Albuminuria

  • Nephritis

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Oraprine

  • Prednisone

  • Tacrolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved